304 related articles for article (PubMed ID: 28436233)
1. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
Chiou YY; Lee YC; Chen MJ
Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
[TBL] [Abstract][Full Text] [Related]
2. Interventions for focal segmental glomerulosclerosis in adults.
Hodson EM; Sinha A; Cooper TE
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD003233. PubMed ID: 35224732
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
Lieberman KV; Tejani A
J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
[TBL] [Abstract][Full Text] [Related]
5. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
Soliman AR; Maamoun H; Soliman H; Ahmed RM
Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
[No Abstract] [Full Text] [Related]
6. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
Shatat IF; Schoeneman M; Flynn JT; Woroniecki RP
Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.
Braun N; Schmutzler F; Lange C; Perna A; Remuzzi G; Risler T; Willis NS
Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD003233. PubMed ID: 18646090
[TBL] [Abstract][Full Text] [Related]
8. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
Segarra Medrano A; Vila Presas J; Pou Clavé L; Majó Masferrer J; Camps Doménech J
Nefrologia; 2011; 31(3):286-91. PubMed ID: 21468162
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine therapy in steroid-dependent or steroid-resistant idiopathic focal and segmental glomerulosclerosis.
Gorsane I; Helal I; Yacoub I; Hamida FB; Abderrahim E; Abdallah TB
Saudi J Kidney Dis Transpl; 2016; 27(5):958-965. PubMed ID: 27752004
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of collapsing focal segmental glomerulosclerosis.
Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
[TBL] [Abstract][Full Text] [Related]
13. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
15. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A; Noël LH; Auriche P; Callard P
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[TBL] [Abstract][Full Text] [Related]
16. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up.
Segarra A; Vila J; Pou L; Majó J; Arbós A; Quiles T; Piera LL
Nephrol Dial Transplant; 2002 Apr; 17(4):655-62. PubMed ID: 11917061
[TBL] [Abstract][Full Text] [Related]
18. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis.
Chang JW; Yang LY; Wang HH
Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834
[TBL] [Abstract][Full Text] [Related]
19. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
